Y. Green

Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Randomized Controlled Study

R. B. Henderson, P. Merkel, D. Blockmans, 2019, Arthritis & Rheumatology.

A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis.

B. Rovin, Xueqing Yu, R. Furie, 2021, Kidney international.

Renal response at 2 years post biopsy to predict long-term renal survival in lupus nephritis: a retrospective analysis of the Hopkins Lupus Cohort

A. Madan, M. Petri, Y. Green, 2022, Lupus Science & Medicine.

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.

B. Rovin, Xueqing Yu, Z. Amoura, 2020, The New England journal of medicine.

Safety and Efficacy of Belimumab in Patients with Lupus Nephritis

A. Madan, B. Rovin, F. Houssiau, 2022, Clinical journal of the American Society of Nephrology : CJASN.

Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population.

A. Madan, Xiao Li, H. Ren, 2022, American journal of kidney diseases : the official journal of the National Kidney Foundation.

OP0164 BLISS-LN: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS

B. Rovin, Xueqing Yu, Z. Amoura, 2020 .

Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data

D. D'cruz, A. Hammer, B. Ji, 2023, Lupus Science & Medicine.